// App-Quantinova.ai

1927 : Co-Morbidity Profile Influences Work, Daily Life and Health-Related Quality-of-Life in Persons with Chronic Myeloid Leukemia Receiving Tyrosine Kinase-Inhibitor Therapy

Researchers

Presenter

  • Qian Jiang

Principal Investigators

  • Xiao-jun Huang

  • Lu Yu

  • Robert Peter Gale

Medical Centers

  • Peking University Peoples Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

  • Institute of Hematology, Peking University Peoples Hospital, Beijing,

Locations

  • China

Companies

  • Celgene Corporation

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

  • Metabolic syndrome

  • Hypertension

  • Venous thrombosis

  • Diabetes

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • L-Tyrosine

  • Suloctidil

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved